Página 14 - Melhores Ecografia médicos - TOP-504 médicos

Professional experience

2007. Director of the Assisted Reproduction Unit of the Quironsalud University Hospital of Madrid since its opening.

2004-06 Private consultation on assisted reproduction in Madrid.

1994-96. Deputy Physician. Department of Gynecology and Obstetrics. Hospital 12 de Octubre, Madrid.

Membership in scientific societies

-He is a member of the Spanish Society of Gynecology and Obstetrics (SEGO).

-Spanish Society of Fertility (SEF);

-European Society of Human Reproduction (ESHRE)

-American Society for Reproductive Medicine (ASRM).

Research and Teaching

In recent years, he has conducted over 30 conferences, 20 presentations and 15 talks at courses and conferences in his specialty. He has written 5 book chapters and coordinated 4 monographs.

2010 Associate Professor. European University of Madrid.

2004-07 Professor of Master in Human Reproduction. Spanish Fertility Society and Complutense University.

1990-98 Professor, PhD student. Training Center for Medical Specialists (CTO)

Dr. Alper Karaoglan is a Professor of Neurosurgery at Memorial Bodrum Hospital. He has many years of experience in neurosurgery. He worked at Maltepe University Faculty of Medicine and Taksim Training and Research Hospital in Istanbul. Since 2008, he has held the positions of Professor, Associate Professor, and Assistant Professor in neurosurgery.

Dr. Karaoglan is a member of the Turkish Medical Association and the Turkish Neurosurgical Society. He has received several awards. These include the Best Paper Award at the Turkish Neurosurgical Society Scientific Congress in 2005 for his research on resveratrol’s protective effects after subarachnoid hemorrhage, and the Young Neurosurgeon Encouragement Award in 2008.

Education

Major degree in Medicine and Surgery (MBBS) Medical School University of Perugia, Italy. (2000-2006)

Internship at the Department of Cardiac Surgery, “S. Maria della Misericordia” University Hospital, Perugia, Italy. (2005 – 2006)

Clinical registration for Medicine and Surgery, “S. Maria della Misericordia” University Hospital, Perugia, Italy. (2006 – 2007)

Completion of the Italian Board Exams for the Medical and Surgical profession (Esame di Stato). Marks 262.5 / 270. Medical School University of Perugia, Italy. (June 2007)

Certificate of Completion of Training (CCT) in Cardiac Surgery. Marks 50/50. Thesis: “Trans-catheter Aortic Valve Implantation (TAVI) – A single centre experience”. Department of Cardio-thoracic Surgery “San Matteo” University Hospital, Pavia, Italy. (July 2014)

Training and Professional Experience

Junior Clinical Fellow in Cardiac Surgery, Department of Cardiac Surgery, “S. Maria della Misericordia” University Hospital, Perugia, Italy. (2007 – 2008)

Clinical Fellow in Cardiac Surgery, Department of Cardiac Surgery, “S. Maria della Misericordia” University Hospital, Perugia, Italy. (2008 – 2009)

Resident in Cardiac Surgery (CTh), Department of Cardio-thoracic Surgery, “San Matteo” University Hospital, Pavia, Italy. (2009 – 2014)

Cardiac Surgery Trainees Representative and Member of the Board of the School of Cardiac Surgery. “San Matteo” University Hospital, Pavia, Italy. (2011 – 2014)

Fellowship in Heart Transplant, Department of Cardio-thoracic Surgery “San Matteo” University Hospital, Pavia, Italy. (2011 – 2012)

Fellowship in Trans-catheter Aortic Valve Implantation (TAVI), Department of Cardio-thoracic Surgery “San Matteo” University Hospital, Pavia, Italy. (2013 – 2014)

Chief Resident in Cardiac Surgery, Department of Cardio-thoracic Surgery, “San Matteo” University Hospital, Pavia, Italy. (2013 – 2014)

Fellowship in Adult Cardiac Surgery, Department of Cardio-thoracic Surgery, St. Georges University Hospital, London, UK. (2014 – 2015)

Senior Specialty doctor in Cardiac Surgery, Department of Cardio-thoracic Surgery, Hull and East Yorkshire University Hospital, Hull, UK. (2015 – 2022)

Lead of Trust Appointed Doctors to the SCTS for the Cardio-thoracic Unit, Department of Cardio-thoracic Surgery, Hull and East Yorkshire University Hospital, Hull, UK. (2020 – 2022)

Director of the Cardiac Surgery Unit, German Medical Institute, Limassol, Cyprus. (2022 – present)

Scientific Activity

MD: Thesis: “The importance of the surgical timing on post-operative outcome in patients with acute endocarditis of native valve”. Medical School University of Perugia, Italy. (April 2005 – December 2006)

Collaborator at the multi-centre National project “Effects of Covid-19 Pandemic on the Provision of Cardiac Surgery in the UK”. Department of Cardio-thoracic Surgery, Hull and East Yorkshire University Hospital, Hull, UK. (2020 – 2022)

Co-investigator at the COMICs multi-centre International Randomised Controlled Trial (RCT) comparing Mini-Bypass (MIECC) with conventional bypass. Department of Cardio-thoracic Surgery, Hull and East Yorkshire University Hospital, Hull, UK. (2018 – 2022)

Co-investigator at the ROUTE multi-centre international registry, aimed to analyse the effectiveness and safety of Transaortic (TAo)-TAVI as a first line approach and to compare it to patients receiving TAo-TAVI as a last resort, which is current practice. Department of Cardio-thoracic Surgery, “San Matteo” University Hospital, Pavia, Italy. (2013 – 2014)

Special Interest

Myocardial revascularisation (coronary by-pass surgery with MIECC)

Aortic surgery (thoracic aorta aneurysm repair)

Aortic valve replacement or repair (minimal invasive, TAVI)

Mitral valve surgery (replacement or repair)

Heart transplant

Memberships

Founder member of the Cypriot Society of Cardiothoracic surgeons (CSCTS)  founded in 2023.

Member of the European Association for Cardiothoracic Surgery (EACTS)

Member of the Society for Cardiothoracic Surgery (SCTS) in Great Britain and Ireland

Registration at the Cypriot Ministry of Health as Specialist in Cardiac Surgery (2016)

GMC-UK Specialist Register: Cardiothoracic Surgery (2014)

Italian Medical Council (Ordine dei Medici-Chirurghi): Full Registration with Licence to practise (2008 – 2014)

Com 41 anos de experiência, o médico é um urologista altamente qualificado na Alemanha. Ele se formou na Universidade Johannes Gutenberg de Mainz e completou seu doutorado em nefrologia em 1980. Desde 1994, atua como professor na Universidade Goethe em Frankfurt am Main. Seu foco clínico inclui oncologia urológica, tratamento minimamente invasivo do câncer de próstata, operações de tumores renais preservando o órgão e urologia reconstrutiva. O médico é autor de mais de 100 artigos científicos, contribuindo significativamente para o campo da urologia.<\/p>

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

O médico completou os estudos de medicina na Universidade de Viena em 1998, com formação na UCLA e na Universidade da Pensilvânia. De 2000 a 2006, o médico treinou como especialista em medicina interna no Hospital Geral de Viena, seguido de especialização adicional em gastroenterologia e hepatologia de 2006 a 2008, e em medicina intensiva interna de 2008 a 2010.<\/p>

O médico estabeleceu e geriu o laboratório de hemodinâmica hepática e a clínica ambulatorial para cirrose na Universidade Médica de Viena em 2003. Desde 2018, o médico é chefe do Departamento de Medicina Interna I no Hospital dos Irmãos da Misericórdia de Viena.<\/p>

O médico é especialista em cirurgia geral e visceral, atuando como cirurgião no Departamento de Cirurgia Geral da Universidade Médica de Viena. Liderando a equipe de cirurgia gástrica e esofágica, o médico também é o Chefe da Unidade de Tumores Gastroesofágicos no Centro de Câncer Compreensivo em Viena.<\/p>

Com mais de 240 artigos especializados publicados, o médico ocupou cargos significativos, como Secretário-Geral da Sociedade Austríaca de Oncologia Cirúrgica desde 2014 e Chefe do Serviço de GI Superior desde 2012. O médico é Professor Associado de Cirurgia e tem sido especialista em cirurgia de GI superior desde 2007.<\/p>

Professor Marek Ehrlich is a cardiac surgeon at University Hospital Vienna. He has led the hospital’s aneurysm program since 2010. He graduated from the Medical University of Vienna and specializes in cardiac surgery. He has also trained internationally at Stanford, Birmingham, Houston, and Mount Sinai Hospital in New York.

Dr. Ehrlich has published over 100 scientific articles on aneurysm surgery. He has led research in neuroprotection and endovascular techniques. He has received several international awards for his work. Dr. Ehrlich often speaks at major global conferences. He is fluent in English and Polish.

Prof. Gil Raviv, MD, PhD, is Director of the Andrology Unit at Sheba Medical Center. He was listed among the Best Doctors in Israel by Forbes in 2024. He is a leading expert in male fertility, sexual medicine, and reconstructive urology.

His primary focus is male infertility and fertility preservation. He performs advanced semen analysis according to WHO standards. He carries out testicular sperm retrieval (TESE, TESA, MESA) and semen cryopreservation. He also provides comprehensive fertility diagnostics with histological analysis.

He is a Professor at Tel Aviv University. He trained in Siena, Rome, and Tel Aviv. He completed a fellowship in infertility and impotence at Erasme Hospital. He received advanced training in reconstructive urethral surgery in Ghent. He is a member of the European Association of Urology, the International Society for Sexual Medicine, and the Israeli Urological Association.

O médico é um oncocirurgião com 25 anos de experiência, especializado no tratamento do câncer de reto e cólon, cirurgia bariátrica e tratamento do câncer de esôfago.<\/p>

Com mais de 15.000 procedimentos cirúrgicos realizados, o médico realiza mais de 1.000 cirurgias minimamente invasivas anualmente, utilizando técnicas laparoscópicas e robóticas.<\/p>

Membro de sociedades médicas internacionais, o médico é presidente da Associação de Cirurgiões-Endoscopistas na Europa e ministra palestras sobre técnicas cirúrgicas avançadas e laparoscopia.<\/p>

Reconhecido como pioneiro na cirurgia gastrointestinal, o médico foi o primeiro a realizar procedimentos inovadores como a remoção da vesícula biliar pela boca e a primeira excisão total do mesorreto transanal (TaTME).<\/p>

O médico é um oncocirurgião experiente com vasta experiência em urologia. Como chefe do Departamento de Urologia da Samsung, o médico liderou numerosos procedimentos cirúrgicos inovadores e contribuiu para avanços significativos na área. O médico é reconhecido pela sua expertise em técnicas minimamente invasivas e foi fundamental no desenvolvimento de novos protocolos para o tratamento do câncer. O médico é altamente respeitado pelo seu compromisso com o cuidado ao paciente e recebeu múltiplos elogios por suas contribuições à pesquisa médica e à educação.<\/p>

O médico é um ginecologista altamente qualificado com foco especializado em oncoginecologia, oferecendo cuidados especializados no diagnóstico e tratamento de cânceres ginecológicos. Com ampla experiência em abordagens cirúrgicas e não cirúrgicas, o médico está comprometido em avançar a saúde das mulheres através de tratamentos inovadores e cuidados compassivos.<\/p>

O médico é um oncoginecologista experiente com vasta experiência no tratamento de cânceres ginecológicos. Especializando-se em técnicas cirúrgicas avançadas e planos de tratamento personalizados, o médico contribuiu significativamente para melhorar os resultados dos pacientes. Com inúmeras publicações em revistas revisadas por pares, o médico é reconhecido por sua expertise em procedimentos minimamente invasivos e foi palestrante principal em conferências internacionais.<\/p>

O médico possui certificação do conselho em oncologia ginecológica e está ativamente envolvido em pesquisa clínica, focando em terapias inovadoras e métodos de detecção precoce. O médico é afiliado a uma instituição médica líder e colabora com equipes multidisciplinares para fornecer cuidados abrangentes.<\/p>

O médico é um oncologista altamente experiente com foco em tratamentos inovadores contra o câncer e cuidados personalizados ao paciente. Com mais de 15 anos de experiência na área, o médico contribuiu significativamente para os avanços na quimioterapia e imunoterapia. O médico é certificado pelo conselho e publicou numerosos artigos de pesquisa em revistas médicas de prestígio. O médico também está ativamente envolvido em ensaios clínicos e foi palestrante principal em várias conferências internacionais de oncologia.<\/p>

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Dr. Zohar Dotan is Head of the Urology Department at Sheba Medical Center. He is a leading uro-oncologist and a pioneer of robotic and laparoscopic urologic surgery in Israel.

He has authored more than 50 scientific publications. He is a regular speaker at international conferences. He has received awards from the American Association of Clinical Surgery, including recognition for research in prostate cancer treatment.

Leadership and credentials: Head of the Israeli Uro-Oncology Society. Assistant Professor at Tel Aviv University. Member of the Israeli, American, and European Urological Associations. Training: MD from Tel Aviv University and a PhD in Genetics. Urology residency at Sheba Medical Center. Fellowship in uro-oncology and laparoscopic surgery at Memorial Sloan Kettering, New York.

O médico é um gastroenterologista de destaque especializado no tratamento de cânceres de pâncreas, ducto biliar e vesícula biliar. Com ampla experiência, o médico atua como especialista em gastroenterologia no Departamento de Gastroenterologia do Samsung Medical Center.<\/p>

O médico completou sua educação médica na Faculdade de Medicina da Universidade de Hanyang na Coreia do Sul, com treinamento adicional na Escola de Medicina da Universidade de Stanford nos EUA e no Hospital da Cruz Vermelha de Kyoto no Japão. O médico também é membro ativo da Sociedade Coreana de Endoscopia Gastrointestinal e da Sociedade Coreana de Gastroenterologia.<\/p>

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

O médico é um gastroenterologista líder na Coreia do Sul e na Ásia, especializado no tratamento de cânceres de pâncreas, ducto biliar e vesícula biliar, bem como pancreatite e cálculos biliares.<\/p>

Atualmente praticando no Samsung Medical Center, o médico tem formação educacional da Faculdade de Medicina da Universidade Nacional de Seul e da Universidade da Califórnia.<\/p>

O médico é membro ativo de várias organizações profissionais, incluindo a Sociedade Coreana de Endoscopia Gastrointestinal, a Sociedade Coreana de Gastroenterologia e a Associação Coreana de Pancreatobiliar.<\/p>

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.